Active Ingredients
Dimethicone 12.10%, Glycerin 0.0015%, Lanolin 2.00%, Titanium Dioxide 1.96%
Tonymoly Pandas Dream Brightening Eye Base
FDA Label NDC 59078-150
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Tonymoly Co., Ltd. for the product Tonymoly Pandas Dream Brightening Eye Base (NDC 59078-150). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purpose, use, caution, keep out of reach of children, directions, inactive ingredients, principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Skin Protectant
Use
This portable Stick-type Eye Base brightens up areas around the eyes with its speedy coverage.
Caution
For external use only. Avoid contact with eyes. Keep out of reach of children. Discontinue use if signs of irritation and/or rash appear.
Keep Out Of Reach Of Children
Keep out of reach of children.
Directions
Apply it around the eyes where you have dark circles and blemishes and pat lightly to absorb.
Inactive Ingredients
Caprylic/Capric Triglyceride, Isopropyl Myristate, Methyl Methacrylate Crosspolymer, Mica, Euphorbia Cerifera (Candelilla) Wax, Dimethicone/Vinyl Dimethicone, Crosspolymer, Microcrystalline Wax, Sorbitan Olivate, Ceresin, Sorbitan Sesquioleate, Caprylyl Glycol, Ethylhexylglycerin, Fragrance, Methicone, Tropolone, Triethoxycaprylylsilane, Pearl Extract, Water, Bambusa Vulgaris Shoot Extract, Bambusa Vulgaris Sap Extract, Steareth-20, N-Hydroxysuccinimide, Chlorhexidine Digluconate, Potassium Sorbate, Chrysin, Palmitoyl Oligopeptide, Palmitoyl Tetrapeptide-7
Principal Display Panel
Product (Panda S Dream Brightening Eye Base Box Final Out V4)
* Please review the disclaimer below.
